Data updated: Mar 10, 2026
LAMICTAL CD
LAMOTRIGINE
Approved 1998-08-24
8
Indications
--
Phase 3 Trials
27
Years on Market
Details
- Status
- Discontinued
- First Approved
- 1998-08-24
- Routes
- ORAL
- Dosage Forms
- TABLET, FOR SUSPENSION
LAMICTAL CD Approval History
Loading approval history...
What LAMICTAL CD Treats
8 FDA approvalsOriginally approved for its first indication in 1998 . Covers 8 distinct patient populations.
- Other (8)
Other
(8 approvals)- • Approved indication (Aug 1998)Label Letter
- • Approved indication (Dec 1998)Label Letter
- • Approved indication (May 2001)Label
- • Approved indication (Jan 2003)Label
- • Approved indication (Jun 2003)Label Letter
- • Approved indication (Jan 2004)Letter
- • Approved indication (Sep 2006)Label Letter
- • Approved indication (May 2015)Label Letter
🔬
Pro Active Pipeline
Ongoing clinical trials by development phase
Loading...
⭐
Pro Key Completed Trials
Completed studies with published results, ranked by significance
Loading...
📊
Trial Timeline
Full development history with FDA approval milestones
Loading...
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
LAMICTAL CD FDA Label Details
ProWant competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.